Etcamah

Medicinal product

(Invented) name

Etcamah

Active substance (s)

Kamizestrantas

Strength

75 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02BA05, camizestrant

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2026-07-20

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kamizestrantas	75 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121800	107909	1107909	dalomoji lizdinė plokštelė	N28		Receptinis	EU/1/26/2046/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-07-20	Registruotas